Skip to main content

Table 2 Maternal and neonatal biochemical indices

From: The impact of oral carbohydrate-rich supplement taken two hours before caesarean delivery on maternal and neonatal perioperative outcomes -- a randomized clinical trial

 

Ch-R group

(n = 30)

Placebo group

(n = 29)

Fasting group

(n = 29)

P

Maternal biochemical indices

 Before intervention

  Glucose (mmol/L)

4.2 (4.0–4.4)

4.1 (4.0–4.6)

4.2 (4.0–4.3)

0.800

  Insulin (mU/L)

11.3 (8.9–14.8)

11.5 (9.0–14.6)

11.6 (9.0–14.6)

0.976

  HOMA-IR

2.1 (1.6–2.9)

2.2 (1.6–2.9)

2.2 (1.6–2.9)

0.988

 Postoperative

  Glucose (mmol/L)

4.2 (3.6–4.7)

4.3 (3.9–4.7)

4.4 (3.9–4.8)

0.395

  Insulin (mU/L)

4.6 (2.8–7.6) *#

8.0 (4.5–13.3) *

8.6 (5.0–11.5) #

0.004

  HOMA-IR

0.9 (0.5–1.5) *#

1.6 (0.8–2.6) *

1.6 (0.9–2.3) #

0.004

 1-day after CD

  Glucose (mmol/L)

3.9 (3.7–4.2)

3.9 (3.5–4.1)

3.7 (3.1–4.2)

0.313

  Insulin (mU/L)

2.9 (1.8–4.9)

1.8 (1.3–2.8)

2.7 (1.8–4.3)

0.050

  HOMA-IR

0.5 (0.3–0.8)

0.3 (0.2–0.5)

0.5 (0.3–0.7)

0.059

Neonatal biochemical indices

  

 Glucose (mmol/L)

3.2 (2.9–3.7) *

3.0 (2.8–3.3)

3.0 (2.8–3.2) *

0.032

  1. Data are expressed as median (Q1-Q3). Women in the Ch-R group received 400 ml oral carbohydrate-rich solution 2 hours before the surgery. Women in the placebo group took 400 ml clear water 2 hours before the surgery. Women in the fasting group received preoperative fasting. Biochemical indices before intervention were measured at 2 hours before the surgery (before preoperative carbohydrate-rich solution or water was taken), while indices immediately after and 1-day after CD were obtained when they returned to the ward from the surgery room immediately and 6:00 AM on the day after the surgery day, respectively. HOMA-IR homeostatic model assessment of insulin resistance, CD caesarean delivery. *# P < 0.05 for between group comparison